Cargando…

MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer

SIMPLE SUMMARY: Prostate cancer is one of the most common and lethal tumors in men worldwide. Due to the high heterogeneity of the disease, the optimal treatment choice for individual patients is very challenging, thus leading to treatment failure caused by poor responsiveness and/or tumor recurrenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doldi, Valentina, El Bezawy, Rihan, Zaffaroni, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156532/ https://www.ncbi.nlm.nih.gov/pubmed/34069147 http://dx.doi.org/10.3390/cancers13102380

Ejemplares similares

miR-1272 Exerts Tumor-Suppressive Functions in Prostate Cancer via HIP1 Suppression
por: Rotundo, Federica, et al.
Publicado: (2020)

miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition
por: El Bezawy, Rihan, et al.
Publicado: (2019)

SPOP Deregulation Improves the Radiation Response of Prostate Cancer Models by Impairing DNA Damage Repair
por: El Bezawy, Rihan, et al.
Publicado: (2020)

miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
por: Martini, Silvia, et al.
Publicado: (2021)

Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables
por: Gandellini, Paolo, et al.
Publicado: (2021)

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
por: El Bezawy, Rihan, et al.
Publicado: (2017)

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma
por: El Bezawy, Rihan, et al.
Publicado: (2022)

MicroRNAs as potential therapeutic targets for pancreatic cancer
por: Chu, Xiangyu, et al.
Publicado: (2022)

MicroRNAs as biomarkers in glaucoma and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2022)

MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
por: Lin, Hui-Ming, et al.
Publicado: (2018)

Epigenetics and MicroRNAs in Cancer
por: Ramassone, Alice, et al.
Publicado: (2018)

MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis
por: Ji, Xiao, et al.
Publicado: (2016)

MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer
por: Paone, Alessio, et al.
Publicado: (2011)

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer
por: Yang, Ying, et al.
Publicado: (2022)

Targeting MicroRNAs in Prostate Cancer Radiotherapy
por: Ni, Jie, et al.
Publicado: (2017)

Epigenetics and microRNAs in UGT1As
por: Meng, Cui-Lan, et al.
Publicado: (2021)

The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma
por: Zhu, Bingying, et al.
Publicado: (2018)

MicroRNAs as Mediators of Adipose Thermogenesis and Potential Therapeutic Targets for Obesity
por: Ma, Lunkun, et al.
Publicado: (2022)

Therapeutic opportunities for targeting microRNAs in cancer
por: Taylor, Molly A, et al.
Publicado: (2014)

MicroRNAs as Therapeutic Targets in Nasopharyngeal Carcinoma
por: Wang, Sumei, et al.
Publicado: (2019)

Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
por: Raue, Rebecca, et al.
Publicado: (2021)

MicroRNAs as therapeutic targets in cardiovascular disease
por: Laggerbauer, Bernhard, et al.
Publicado: (2022)

The Therapeutic Potential of MicroRNAs in Atrial Fibrillation
por: Xu, Xiaona, et al.
Publicado: (2020)

Cardiac microRNAs: diagnostic and therapeutic potential
por: Kabłak-Ziembicka, Anna, et al.
Publicado: (2023)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

MicroRNAs as Epigenetic Targets of Cigarette Smoke During Embryonic Development
por: Seelan, Ratnam S., et al.
Publicado: (2020)

MicroRNAs: an emerging science in cancer epigenetics
por: Kala, Rishabh, et al.
Publicado: (2013)

MicroRNAs: Important Epigenetic Regulators in Osteoarthritis
por: Trzeciak, Tomasz, et al.
Publicado: (2014)

Epigenetic Regulation of Innate Immunity by microRNAs
por: Boosani, Chandra S., et al.
Publicado: (2016)

MicroRNAs as potential target in human bone and soft tissue sarcoma therapeutics
por: Varshney, Jyotika, et al.
Publicado: (2015)

Promoter methylated microRNAs: Potential therapeutic targets in gastric cancer (Review)
por: GUO, XIAOQIANG, et al.
Publicado: (2015)

Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer
por: Tsai, Ming-Ming, et al.
Publicado: (2016)

Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy
por: Chen, Tai-Heng
Publicado: (2020)

What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
por: Guterres, Alexandro, et al.
Publicado: (2020)

MicroRNAs in mouse and rat models of experimental epilepsy and potential therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2023)

MicroRNAs as a therapeutic target for cardiovascular diseases
por: Mishra, Paras Kumar, et al.
Publicado: (2009)

MicroRNAs: New Therapeutic Targets for Familial Hypercholesterolemia?
por: Momtazi, Amir Abbas, et al.
Publicado: (2017)

MicroRNAs in Parkinson's disease and emerging therapeutic targets
por: Martinez, Bridget, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gph1bmb45457qa8eefmn79r5vs